Intralesional Bevacizumab Injection on Primary Pterygium

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate that intralesional injection of bevacizumab on primary pterygium can reduce the corneal pterygium area, inflammation, redness and other symptoms.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Khon Kaen University
• Treatments: Antazoline; Bevacizumab; Histamine Antagonists; Histamine H1 Antagonists; Tetrahydrozoline; Vasoconstrictor Agents

Criteria

Inclusion Criteria:

• primary pterygium

Exclusion Criteria:

• previous ocular surgery